OTTAWA, ON – Innovative Medicines Canada (IMC) is pleased to announce Dr. Bettina Hamelin has been appointed as its new President, effective April 8, 2024. Dr. Hamelin, PharmD, EMBA, comes to IMC… Read More
Research institutions in the United States, Canada, Israel, and Belgium, including Johns Hopkins University, will study PEX010, Filament’s botanical psilocybin drug candidate VANCOUVER, BC – Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament” or… Read More
VICTORIA, BC – GuideStar Medical Devices (GuideStar) announces successful first clinical use of its flagship device, EpiZact. EpiZact, which was recently granted U.S. Food and Drug Administration (FDA) 510(k) clearance,… Read More
Transaction includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities Fusion shareholders to receive $21.00 per share in cash at closing plus a… Read More
Four $50,000 financial grants will be awarded to deserving Canadian public high schools to enhance scientific learning. Recipients can use the funds to renovate existing laboratory facilities, purchase new scientific equipment, develop… Read More
